MedPath

Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing

Not Applicable
Not yet recruiting
Conditions
Youth Mental Health and Wellbeing
Feasibility and Acceptability of the Social Prescribing Program
Registration Number
NCT07022561
Lead Sponsor
University of Ottawa
Brief Summary

The goal of this clinical trial is to learn if the Social Prescription (SP) intervention helps improve mental health and wellbeing in youth. It will also assess the feasibility and acceptability of implementing SP in a community setting. The main questions it aims to answer are:

* Is the SP intervention feasible and acceptable for youth, caregivers, and staff?

* Does the SP intervention improve mental health outcomes, reduce stress, and increase wellbeing and social connectedness in youth?

Researchers will compare the Social Prescription (SP) intervention to an education control group to evaluate its effectiveness in improving youth mental health and wellbeing.

Participants will:

* Be randomized to receive either the SP intervention or be placed in an education control group

* Complete wellbeing and mental health questionnaires at the beginning of the study and again after 12 weeks

* Participate in qualitative interviews to share their experiences after participating in SP

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
170
Inclusion Criteria
  • between 11-17 years of age
  • on the waitlist for mental health services
  • are not an immediate safety threat to themselves or others as assessed by the HEADS ED questionnaire
Exclusion Criteria
  • Children < 11 years old
  • Adolescents > 17 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Revised Children's Anxiety and Depression ScaleFrom enrollment to end of treatment or control period at 12 weeks.

The Revised Children's Anxiety and Depression Scale (RCADS) is a self-report questionnaire that measures symptoms of anxiety and depression in children and adolescents aged 8 to 18.

Perceived Stress ScaleFrom enrollment to end of treatment or control period at 12 weeks.

The Perceived Stress Scale is a widely used to help understand how different situations affect our feelings and our perceived stress.

Warwick-Edinburgh Mental Wellbeing ScaleFrom enrollment to end of treatment or control period at 12 weeks

The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) was developed to enable the monitoring of mental wellbeing in the general population and the evaluation of projects, programmes and policies which aim to improve mental wellbeing.

Social Connectedness ScaleFrom enrollment to end of treatment or control period at 12 weeks

The Social Connectedness Scale measures the extent to which individuals feel connected to others in their social environment.

Student Resilience SurveyFrom enrollment to end of treatment or control period at 12 weeks

Student Resilience Survey measuring students' perceptions of their individual characteristics as well as protective factors embedded in the environment:

Secondary Outcome Measures
NameTimeMethod
Acceptability of Intervention MeasureFrom enrollment to end of treatment or control period at 12 weeks

The Acceptability of Intervention Measure evaluates how agreeable or satisfactory an intervention is perceived to be by participants or implementers.

Intervention Appropriateness MeasureFrom enrollment to end of treatment or control period at 12 weeks

The Intervention Appropriateness Measure assesses the perceived relevance or suitability of an intervention for a specific setting or population.

Feasibility of Intervention MeasureFrom enrollment to end of treatment or control period at 12 weeks

The Feasibility of Intervention Measure gauges how practical and possible it is to implement an intervention within a given setting.

Trial Locations

Locations (1)

University of Ottawa

🇨🇦

Ottawa, Ontario, Canada

University of Ottawa
🇨🇦Ottawa, Ontario, Canada
Nicole Racine, PhD, C. Psych
Contact
403-992-7869
nracine2@uottawa.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.